Back
Xylem, Inc. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
60
XYL
Xylem, Inc.
Last Price:
$140.87
Seasonality Move:
2.29%
Buy
67
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Buy
60
Xylem, Inc. (XYL)
is a Buy
Is Xylem, Inc. a Buy, Sell or Hold?
-
The current Xylem, Inc. [XYL] share price is $140.89. The Score for XYL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
XYL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $90.01. The Score for DRUG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XYL Stock Price Chart
What is Xylem, Inc.'s stock price today?
-
The Xylem, Inc. share price today is $140.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XYL is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $90.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 54.61 | Buy |
| Chaikin Money Flow: | 727432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.17 - 139.97) | Buy |
| Bollinger Bands (100): | (138.63 - 147.39) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.79 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -196363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.34 - 89.1) | Buy |
| Bollinger Bands (100): | (46.01 - 75.51) | Buy |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.74 | Buy |
| 20-day SMA: | 138.42 | Buy |
| 50-day SMA: | 142.09 | Sell |
| 200-day SMA: | 134.47 | Buy |
| 8-day EMA: | 139.31 | Buy |
| 20-day EMA: | 139.11 | Buy |
| 50-day EMA: | 140.63 | Buy |
| 200-day EMA: | 137 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.17 | Buy |
| 20-day SMA: | 84.39 | Buy |
| 50-day SMA: | 70.26 | Buy |
| 200-day SMA: | 45.73 | Buy |
| 8-day EMA: | 86.85 | Buy |
| 20-day EMA: | 82.54 | Buy |
| 50-day EMA: | 73.48 | Buy |
| 200-day EMA: | 51.43 | Buy |
Xylem, Inc. Earnings Growth & XYL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.61 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.03 per share, and a decrease next year of $3.86 per share.
Xylem, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||